NR2C2 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P49116 |
---|---|
Clone Names | 100517043 |
Gene ID | 7182 |
---|---|
Other Names | Nuclear receptor subfamily 2 group C member 2, Orphan nuclear receptor TAK1, Orphan nuclear receptor TR4, Testicular receptor 4, NR2C2, TAK1, TR4 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NR2C2 |
---|---|
Synonyms | TAK1, TR4 |
Function | Orphan nuclear receptor that can act as a repressor or activator of transcription. An important repressor of nuclear receptor signaling pathways such as retinoic acid receptor, retinoid X, vitamin D3 receptor, thyroid hormone receptor and estrogen receptor pathways. May regulate gene expression during the late phase of spermatogenesis. Together with NR2C1, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription including that of GATA1. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Plays a fundamental role in early embryonic development and embryonic stem cells. Required for normal spermatogenesis and cerebellum development. Appears to be important for neurodevelopmentally regulated behavior (By similarity). Activates transcriptional activity of LHCG. Antagonist of PPARA-mediated transactivation. |
Cellular Location | Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407, ECO:0000269|PubMed:10644740, ECO:0000269|PubMed:15302918} |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Members of the nuclear hormone receptor family, such asNR2C2, act as ligand-activated transcription factors. The proteinshave an N-terminal transactivation domain, a central DNA-bindingdomain with 2 zinc fingers, and a ligand-binding domain at the Cterminus. The activated receptor/ligand complex is translocated tothe nucleus where it binds to hormone response elements of targetgenes (Yoshikawa et al., 1996 [PubMed 8661150]).
References
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Srivastava, R., et al. J. Biol. Chem. 285(15):11100-11105(2010)Ear, T., et al. J. Immunol. 184(7):3897-3906(2010)Suzuki, S., et al. J. Biol. Chem. 285(7):4441-4446(2010)Huang, Y.H., et al. J. Cell. Physiol. 222(2):347-356(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.